IMNN
Imunon, Inc. - Common Stock (IMNN)
$72
About Imunon, Inc. - Common Stock (IMNN)
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
Details
Daily high
$2.76
Daily low
$2.70
Price at open
$2.76
52 Week High
$41.22
52 Week Low
$2.52
Market cap
10.7M
Dividend yield
0.00%
Volume
19,047
Avg. volume
35,287
P/E ratio
-.34
Imunon, Inc. - Common Stock News
Details
Daily high
$2.76
Daily low
$2.70
Price at open
$2.76
52 Week High
$41.22
52 Week Low
$2.52
Market cap
10.7M
Dividend yield
0.00%
Volume
19,047
Avg. volume
35,287
P/E ratio
-.34